Related Experiment Video
Updated: Apr 30, 2026

Establishment of a Surgically-induced Model in Mice to Investigate the Protective Role of Progranulin in Osteoarthritis
Published on: February 25, 2014
Progranulin in neurodegenerative disease.
Terri L Petkau1, Blair R Leavitt2
1Centre for Molecular Medicine and Therapeutics, Department of Medical Genetics, University of British Columbia, and Children's and Women's Hospital, 980 West 28th Avenue, Vancouver, BC, Canada V5Z 4H4.
Progranulin gene mutations cause familial frontotemporal dementia (FTD). This review explores progranulin
Area of Science:
- Neuroscience
- Genetics
- Neurology
Background:
- Loss-of-function mutations in the progranulin gene are a significant cause of familial frontotemporal dementia (FTD).
- Progranulin (PGRN) plays a critical role in cellular homeostasis and lysosomal function.
- Understanding PGRN's function is crucial for developing targeted therapies for neurodegenerative diseases.
Purpose of the Study:
- To review the multifaceted role of progranulin in both healthy and diseased states.
- To examine the clinical and neuropathological characteristics of FTD patients with progranulin gene mutations.
- To synthesize evidence on progranulin's function in the brain, particularly from mouse models, to inform therapeutic strategies.
Main Methods:
- Review of clinical and neuropathological data from FTD patients with progranulin gene mutations.
- Examination of evidence for progranulin's role in brain function, with a focus on findings from mouse models.
- Synthesis of current knowledge on progranulin biology and its implications for neurodegeneration.
Main Results:
- FTD associated with progranulin mutations presents a complex phenotype, suggesting multifactorial neurodegeneration.
- Evidence indicates that genetic and environmental factors interact to influence progranulin-mediated neurodegeneration.
- Mouse models provide valuable insights into progranulin's diverse functions within the brain.
Conclusions:
- Progranulin's role in neurodegeneration is complex and influenced by various factors.
- Further understanding of progranulin biology is essential for developing effective therapies.
- Developing therapeutics that modulate endogenous progranulin levels holds promise for treating FTD and other neurodegenerative diseases.
Related Concept Videos
Alzheimer Disease ll: Pathophysiology
Neural Regulation
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Neurogenesis and Regeneration of Nervous Tissue
Parkinson Disease ll: Pathophysiology

